XYXikuang Yao

Xikuang Yao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xikuang Yao has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dual-Stimuli-Driven Calcium Nanomachines for NO-Induced Immunogenic Cell Death

    by Yujie Mao, Xin Li, Juan Qin, Ting Wang, Kang Xia, Duo Wang, Xikuang Yao, Wei Huang

    Tumor blood vascular endothelial cells targeting has emerged as a powerful strategy to enhance the accumulation and penetration of nanomedicines. However, the complex tumor microenvironment, especially the newly discovered breast cancer blood vascular basement membrane, can severely trap accumulated nanomedicines and compromise therapeutic efficacy. In this study, a γ-glutamyl transpeptidase (GGT)-targeting calcium nanomachine is designed and fabricated through decoration of GGT-targeting polysarcosine and encapsulation of nitric oxide (NO) precursors. Upon NIR laser irradiation, these calcium nanomachines can efficiently release NO on demand. By integration of the GGT-targeting and NIR-triggered NO release, these nanomachines can actively target the 4T1 tumor, deeply penetrate into tumor region, and are efficiently internalized by 4T1 cells. Robust tumor cell apoptosis and immunogenic cell death (ICD) can be achieved as well as efficient immune activation. Meanwhile, these calcium nanomachines can also greatly inhibit 4T1 lung metastasis and demonstrate significant efficacy against large tumors. This work offers a great opportunity for the facile design and construction of precision nanomedicines.

  • Controlled Self‐Assembly of Gold Nanoparticles for Photo‐Enhanced Cancer Imaging and Treatment

    by Jiayu He, Kang Xia, Xin Li, Wei Huang, Xikuang Yao

    Gold nanoparticles (AuNPs) show significant potential for application in cancer imaging and treatment due to their excellent biocompatibility, tunable surface modification, and unique localized surface plasmon resonance (LSPR) effect. In recent years, the self‐assembly of AuNPs has emerged as a versatile strategy to meet increasing demands for signal amplification, drug delivery, and therapeutic activation by regulating interparticle spacing and spatial configuration. Compared with dispersed AuNPs, self‐assembled AuNPs significantly enhance near‐infrared absorption, photothermal conversion efficiency, and multimodal imaging performance, while improving tumor retention, deep penetration, and tumor microenvironment (TME)‐responsive behaviors. This review systematically reviews current driving forces for the self‐assembly of AuNPs, including hydrophobic interaction, host–guest interaction, hydrogen bonding, and electrostatic interaction, and focuses on summarizing the latest progress of self‐assembled AuNPs for cancer imaging and treatment. Finally, this review discusses the remaining challenges in this field, including in vivo and in situ assembly regulation, biological safety assessment, and clinical translation, and outlines future research directions.

  • Emerging Nanoreactors for Precision Disease Treatment: From Principles to Biomedical Applications

    by Haobo Chen, Ting Wang, Kang Xia, Xin Li, Xikuang Yao, Wei Huang

    Inspired by natural cellular compartments, nanoreactors are spatially confined nanostructures that precisely regulate chemical and biological reactions and act as high‐performance catalytic nanocontainers. Multifunctional integration of these systems surmounts the inherent limitations of conventional therapeutic modalities. This review focuses on recent breakthroughs in organic and organic–inorganic hybrid nanoreactors, highlighting three core effects: (1) the spatial confinement effect, which elevates the reactant concentration, accelerates mass transfer, lowers activation energy, modulates electronic states, and boosts reaction rates by orders of magnitude; (2) the synergistic effect of active sites, which enables efficient cascade reactions via spatially segregated or hierarchical catalytic architectures; (3) the stimuli‐responsive effect, which dynamically controls catalysis and cargo release under endogenous (pH, enzymes, ROS) or exogenous (light, temperature) cues. Typical nanoreactors (liposomes, polymeric micelles/vesicles, mesoporous silica, protein cages, and organic–inorganic hybrids) are systematically discussed regarding structural merits and biomedical applications in treating diabetes, rheumatoid arthritis (RA), chronic wound healing, cancer, and Alzheimer's disease (AD). Current challenges and future perspectives are also addressed. Intelligent nanoreactors are expected to offer immense potential for disease diagnosis and therapy.


  • GGT-targeting polysarcosine-decorated CaCO3 nanoplatform for ICD-enhanced breast cancer immunotherapy

    by Xikuang Yao, Fei Xiong, Haobo Chen, Xudong Cao, Qinyi Chen, Jiayu He, Liyuan Zhang, Weina Zhang, Wenpei Fan, Xin Li, et al.


  • CD44-targeting and ZIF-8 gated gold nanocage for programmed breast cancer therapy through Pt-induced immunogenic cell death

    by Xin Li, Fei Xiong, Xudong Cao, Wei Liu, Haobo Chen, Jiayu He, Weina Zhang, Longguang Tang, Wei Huang, Xikuang Yao


  • Engineering AIEgens-Tethered Gold Nanoparticles with Enzymatic Dual Self-Assembly for Amplified Cancer-Specific Phototheranostics

    by Jiayi Bian, Yingjie Xu, Minghao Sun, Zerui Ma, Hao Li, Changrui Sun, Fei Xiong, Xiaopeng Zhao, Wenjing Yao, Yue Chen, et al.

    Accurate imaging and precise treatment are critical to controlling the progression of pancreatic cancer. However, current approaches for pancreatic cancer theranostics suffer from limitations in tumor specificity and invasive surgery. Herein, a pancreatic cancer-specific phototheranostic modulator (AuHQ) dominated by aggregation-induced emission (AIE) luminogens-tethered gold nanoparticles is meticulously designed to facilitate prominent fluorescence-photoacoustic bimodal imaging-guided photothermal immunotherapy. Once reaching the pancreatic tumor microenvironment (TME), the peptide Ala-Gly-Phe-Ser-Leu-Pro-Ala-Gly-Cys (AGFSLPAGC) linkage within AuHQ can be specifically cleaved by the overexpressed enzyme Cathepsin E (CTSE), triggering the dual self-assembly of AuNPs and AIE luminogens. The aggregation of AuNPs mediated by enzymatic cleavage results in potentiated photothermal therapy (PTT) under near-infrared (NIR) laser irradiation, induced immunogenic cell death (ICD), and enhanced photoacoustic imaging. Simultaneously, AIE luminogen aggregates formed by hydrophobic interaction can generate AIE fluorescence, enabling real-time and specific fluorescence imaging of pancreatic cancer. Furthermore, coadministration of an indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor with AuHQ can address the limitations of PTT efficacy imposed by the immunosuppressive TME and leverage the synergistic potential to activate systemic antitumor immunity. Thus, this well-designed phototheranostic modulator AuHQ facilitates the intelligent enzymatic dual self-assembly of imaging and therapeutic agents, providing an efficient and precise approach for pancreatic cancer theranostics.


  • Biodegradable persistent ROS-generating nanosonosensitizers for enhanced synergistic cancer therapy by inducing cascaded oxidative stress

    by Yue Chen, Tong Ding, Zhengzheng Qian, Zerui Ma, Liming Zhou, Zhiling Li, Runkai Lv, Yinghui Xu, Yingjie Xu, Linhui Hao, et al.

    Biodegradable CaO 2 @PCN nanosonosensitizers induce sustained ROS production and mitochondrial calcium homeostasis via synergistic sonodynamic/ion interference therapy, ultimately leading to cancer cell death.


  • Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death

    by Xikuang Yao, Changrui Sun, Fei Xiong, Weina Zhang, Wenjing Yao, Yinghui Xu, Wenpei Fan, Fengwei Huo

    Nanomedicine-enhanced immunogenic cell death (ICD) has attracted considerable attention for its great potential in cancer treatment. Even though polyethylene glycol (PEG) is widely recognized as the gold standard for surface modification of nanomedicines, some shortcomings associated with this PEGylation, such as hindered cell endocytosis and accelerated blood clearance phenomenon, have been revealed in recent years. Notably, polysarcosine (PSar) as a highly biocompatible polymer can be finely synthesized by mild ring-opening polymerization (ROP) of sarcosine N-carboxyanhydrides (Sar-NCAs) and exhibit great potential as an alternative to PEG. In this article, PSar-b-polycamptothecin block copolymers are synthesized by sequential ROP of camptothecin-based NCAs (CPT-NCAs) and Sar-NCAs. Then, the detailed and systematic comparison between PEGylation and PSarylation against the 4T1 tumor model indicates that PSar decoration can facilitate the cell endocytosis, greatly enhancing the ICD effects and antitumor efficacy. Therefore, it is believed that this well-developed PSarylation technique will achieve effective and precise cancer treatment in the near future.